Jpmorgan Chase & CO Cor Medix Inc. Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Cor Medix Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 36,237 shares of CRMD stock, worth $403,680. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,237
Previous 273,218 86.74%
Holding current value
$403,680
Previous $2.21 Million 89.92%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
$6.16 - $12.57 $1.46 Million - $2.98 Million
-236,981 Reduced 86.74%
36,237 $223,000
Q4 2024

Feb 12, 2025
BUY
$8.1 - $13.59 $640,791 - $1.08 Million
79,110 Added 40.76%
273,218 $2.21 Million
Q3 2024

Dec 26, 2024
BUY
$3.64 - $8.23 $616,605 - $1.39 Million
169,397 Added 685.51%
194,108 $1.57 Million
Q3 2024

Nov 08, 2024
BUY
$3.64 - $8.23 $616,605 - $1.39 Million
169,397 Added 685.51%
194,108 $1.57 Million
Q2 2024

Dec 26, 2024
SELL
$4.08 - $6.39 $691,139 - $1.08 Million
-169,397 Reduced 87.27%
24,711 $106,000
Q2 2024

Aug 12, 2024
BUY
$4.08 - $6.39 $10,065 - $15,764
2,467 Added 11.09%
24,711 $106,000
Q1 2024

Dec 26, 2024
SELL
$2.94 - $4.24 $505,280 - $728,703
-171,864 Reduced 88.54%
22,244 $94,000
Q1 2024

May 10, 2024
SELL
$2.94 - $4.24 $45,514 - $65,639
-15,481 Reduced 41.04%
22,244 $94,000
Q4 2023

Dec 26, 2024
SELL
$3.0 - $4.01 $469,149 - $627,095
-156,383 Reduced 80.56%
37,725 $141,000
Q4 2023

Feb 12, 2024
BUY
$3.0 - $4.01 $9,468 - $12,655
3,156 Added 9.13%
37,725 $141,000
Q3 2023

Nov 14, 2023
SELL
$3.6 - $4.46 $86,792 - $107,526
-24,109 Reduced 41.09%
34,569 $127,000
Q2 2023

Aug 11, 2023
BUY
$3.94 - $5.8 $230,423 - $339,201
58,483 Added 29991.28%
58,678 $232,000
Q4 2022

Feb 13, 2023
SELL
$2.81 - $4.45 $60,100 - $95,176
-21,388 Reduced 99.1%
195 $1,000
Q3 2022

Nov 14, 2022
SELL
$2.82 - $7.52 $161,557 - $430,820
-57,290 Reduced 72.64%
21,583 $62,000
Q2 2022

Aug 11, 2022
BUY
$2.73 - $5.61 $104,916 - $215,597
38,431 Added 95.03%
78,873 $317,000
Q1 2022

May 11, 2022
BUY
$3.83 - $6.24 $7,537 - $12,280
1,968 Added 5.12%
40,442 $221,000
Q4 2021

Feb 10, 2022
BUY
$4.47 - $5.56 $50,913 - $63,328
11,390 Added 42.05%
38,474 $175,000
Q3 2021

Nov 12, 2021
BUY
$4.46 - $7.11 $120,794 - $192,567
27,084 New
27,084 $126,000

Others Institutions Holding CRMD

# of Institutions
149
Shares Held
22.8M
Call Options Held
475K
Put Options Held
777K
View Full List

About CorMedix Inc.

CRMD Quotes by TradingView
  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $459M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email